Supernus Pharmaceuticals, Inc. (SUPN) - NASDAQ
From other sites
Company Description
Supernus Pharmaceuticals, Inc. develops and commercializes products for the treatment of central nervous system. It also develops multiple product candidates in psychiatry to address the large market opportunity in the treatment of attention deficit hyperactivity disorder, or ADHD, including... More
Sector: Healthcare
Industry: Drugs - Generic
Country: United States